Chinese Journal of Clinical Hepatology 2009 Issue 3 Sdudy the relationship between serum hepatitis B virus deoxyribonucleic acid and circulating dendritic cell subsets in patients with hepatitis B infection

Sdudy the relationship between serum hepatitis B virus deoxyribonucleic acid and circulating dendritic cell subsets in patients with hepatitis B infection
DONG Ja-xiu;ZHAO Shou-song;GAO Ji-jun

..............page:167-170

Relationship between the Antiviral Effect and Changes of Th1/Th2 during the Treatment of Chronic Hepatitis B Using Lamivudine
YAN Shuang-huan;ZHANG Xin-yuan;CAO Zhi-chen

..............page:170-172

Endotoxin and bilirubin removal in ascites of patients with cirrhosis by CA/PEI affinity membrane in vitro
BAI Shu-yan;DUAN Zhi-jun;PAN Ming-chen

..............page:173-174

Comparative Study on the Clinical and Pathological features of HBeAg Negative/Positive Chronic Hepatitis B Patients
WU Li-ping;ZHANG Jian-jun;DU Rui-qing

..............page:175-177

Virological characteristics of HBeAg positive hepatitis B patients with complete response to nucleotside anlogue treatment
GENG Shu-ying;CHEN Jin-jun;WAN Tie-lin

..............page:177-179

Study of liver histopathology in 100 patients with chronic hepatitis B virus infection and with normal ALT levels
JIANG Jun;CHEN Shi-xiang;CHEN Xi-qing

..............page:180-181

Liver fibrosis of chronic HBV infected patients older than 40-year-old with normal ALT
LI Jing

..............page:182-183

Correlations factors involved in therapeutic failure of lamivudine for chronic hepatitis B patients
ZHAN Guo-qing;ZHENG San-ju;ZHU Lin

..............page:184-186

fu zheng hua zuo jiao nang lian he a de fu wei zuo zhi liao man xing yi xing gan yan gan xian wei hua de liao xiao guan cha
jiang zhao jin ; lei ming jun

..............page:186-187

Observation on the efficiency and safety of Entecavir on chronic hepatitis B
HAN Zhi-qi;QIN Bo;ZHANG Hai

..............page:188-190

Short-term observation of Telbivudine in treatment of chronic severe hepatitis B
QIU Shao-qin;LI Wen-yong;PENG Qiu-ping

..............page:190-191

Study on YMDD mutation during Lamivudine therapy of chronic hepatitis B
FAN Xiao-hong;HU Yu-lin;ZHU Hong-lin

..............page:192-194

Distribution of pathogenic bacterial strains and their drug susceptibility in severe liver disease patients with blood and/or ascites infection
WEI Hong;ZHAO Xiu-ying;SUN Gui-zhen

..............page:225-227

mmps zai gan xian wei hua xing cheng yu ni zhuan guo cheng zhong de zuo yong
zhao chun hong ; zhang xiao zuo

..............page:231-235

hbv xiang guan gan shuai jie kang bing du zhi liao jin zhan
he wei ping ; wang hui fen

..............page:235-237

man xing yi xing gan yan gan ying hua de kang bing du zhi liao
wang shou yi

..............page:238-240

man xing yi xing gan yan huan zhe gan huo jian yi yi de zhong xin ping ding
wang yang ; xin gui jie ; jin qing long ; wang feng

..............page:240-封3

ju da gan nong zhong 1 li bao dao
zhang gong ; shi wen juan ; zhang jian jun

..............page:230-230

gao zhi xue zheng he ji xing yi xian yan yan jiu jin zhan
tang yong hui ; miao yi

..............page:227-229

ru he li jie gan ying hua fu shui huan zhe xian na yu bu na wen ti
liu jian jun

..............page:163-166

The study of liver injury in Idiopathic inflammatory myopathy patients with hyperaminotransferase
HE Yu-kai;SHAN Hai-xia;ZHANG Fan

..............page:194-198

Expression of P504S and P63 and their clinicopathological significances in the benign and malignant lesions of gallbladder
LV Fang;YANG Zhu-lin;MIAO Xiong-ying

..............page:199-201

Clinical analysis of serum amino acid in patients with liver cirrhosis and liver cancer
ZHOU Shu-fen;LIU Shu-ye;DING Xian

..............page:202-203

The effects of human hepatocarcinoma HepG2 cell culture supernatant on T lymphocyte activity
ZHANG Ke-chang;WU Jun-ying;LI Bai-qing

..............page:204-206

The clinical effect of Cinobufagin injection by transcatheter arterial chemoembolization (TACE) combined with intravenous on treating primary liver cancer (PLC)
SHEN Jian-jun

..............page:207-209

Observation of curative effect of Bifidobiogen-Livzon and Mosapride on fouty-two cases with liver failure
LI Jian-yang;LIU Fu-wen;HUA Wei

..............page:209-210

Study on the Treatment Mechanisms of Placenta Extracts on Fatty Liver Disease
WANG Bo;CHEN Song-jin;YU Ya-wei

..............page:211-214

Effect of Tiopronin combined with Polyene Phosphatidylcholine on alcoholic liver disease
GAO Yuan-zheng;JIA Su-hua;WANG Yan

..............page:214-216

The curative effect analysis of combining glycerol trinitrate and octreotide for the treatment of liver cirrhosis varicosis hemorrhage
XIANG Zhi-yong;ZHENG Yong;XU Li-hong

..............page:217-218

zong he zhi liao jia xue jiang zhi huan zhi liao gan xing nao bing de liao xiao tan tao
bian chun xiang ; zhang zuo ; wu jun ; wen guo juan ; he shuai ; zou chun yi

..............page:219-220

da ji liang huan yuan xing gu zuo gan zuo lian he gan cao suan er an zhi liao kang jie he yao wu suo zhi zhong du gan sun hai lin chuang liao xiao guan cha
hu qi jiang ; wang hui lan ; li min ; zhang chun lei

..............page:220-221

a de fu wei zuo zhi liao hbeag yang xing man xing yi xing gan yan zao qi ying da yu yuan qi ying da de xiang guan xing
li xian yong ; wang shu ; su zun zuo

..............page:222-223

hbsag/ab shuang yang xing huan zhe xue qing bing du zai liang fen xi
huang xue zhong ; lin pei pei ; chen xiao fei ; zhou ping

..............page:224-224